|
|
Other links at Articles > Cardiology |
| 3. |
No SEISMIC Shift in Outlook for Stem Cell Therapy
|
|
|
Yet another trial of stem cell therapy has failed to deliver any significant results. The phase 1/2 SEISMIC study reported last week did not show any evidence of efficacy with MyoCell skeletal myoblast cell therapy in post-MI heart failure, although the procedure appeared safe. More trials are needed to demonstrate clinical value, experts said. Heartwire
|
| 4. |
Layoffs for Schering-Plough, but One Large Insurer Still Backs Ezetimibe
|
|
|
Schering-Plough Corporation announced that 5500 employees are being laid off, with sales and marketing to be hit first. In other news, the company released more emails between Kastelein and executives, arguing that the primary investigator was not kept out of the loop of important study decisions. Heartwire
|
|
|
